Tilray Brands (NASDAQ: TLRY) Q2 2025 Earnings Call Jan 10, 2025, 8:30 a.m. ET ...

Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year ...

Stock futures dipped on Friday as investors evaluated a much hotter-than-expected December jobs report and awaited the ...

Tilray Brands (TLRY) stock falls 8% in premarket after Q2 revenue misses estimates. However, company reaffirms FY25 guidance ...

Alliance Global Partners lowered the firm’s price target on Tilray (TLRY) to $1.50 from $1.75 and keeps a Neutral rating on the shares.

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments. Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net ...

Reports Q2 net revenue $211M, consensus $216.33M. Irwin Simon, Chairman and CEO of Tilray (TLRY) Brands, stated, “In our fiscal second quarter, ...

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million ...

The TSX slumped 305.78 points, or 1.2%, to close the Friday session at 24,767.73, marking its worst day since December 18 and its first weekly loss in three weeks. On the week, the index was punished ...